PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $165,000 | -25.3% | 43,366 | 0.0% | 0.00% | – |
| Q4 2019 | $221,000 | +20.8% | 43,366 | +19.5% | 0.00% | – |
| Q3 2019 | $183,000 | -18.3% | 36,292 | 0.0% | 0.00% | – |
| Q2 2019 | $224,000 | +32.5% | 36,292 | -0.5% | 0.00% | – |
| Q1 2019 | $169,000 | +10.5% | 36,480 | 0.0% | 0.00% | – |
| Q4 2018 | $153,000 | -22.3% | 36,480 | +16.4% | 0.00% | – |
| Q3 2018 | $197,000 | -18.3% | 31,348 | +4.6% | 0.00% | -100.0% |
| Q2 2018 | $241,000 | -3.6% | 29,964 | -10.5% | 0.00% | 0.0% |
| Q1 2018 | $250,000 | +17.9% | 33,494 | -6.1% | 0.00% | – |
| Q4 2017 | $212,000 | -19.1% | 35,657 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $262,000 | +8.3% | 35,657 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $242,000 | -19.3% | 35,657 | +12.4% | 0.00% | 0.0% |
| Q1 2017 | $300,000 | +9.5% | 31,737 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $274,000 | +36.3% | 31,737 | 0.0% | 0.00% | – |
| Q3 2016 | $201,000 | +50.0% | 31,737 | 0.0% | 0.00% | – |
| Q2 2016 | $134,000 | -2.9% | 31,737 | 0.0% | 0.00% | – |
| Q1 2016 | $138,000 | -29.2% | 31,737 | 0.0% | 0.00% | – |
| Q4 2015 | $195,000 | +7.1% | 31,737 | 0.0% | 0.00% | – |
| Q3 2015 | $182,000 | -40.1% | 31,737 | -22.2% | 0.00% | -100.0% |
| Q2 2015 | $304,000 | +12.6% | 40,813 | -9.6% | 0.00% | 0.0% |
| Q1 2015 | $270,000 | -20.8% | 45,141 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $341,000 | +45.7% | 45,141 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $234,000 | +20.0% | 45,141 | 0.0% | 0.00% | – |
| Q2 2014 | $195,000 | +5.4% | 45,141 | 0.0% | 0.00% | – |
| Q1 2014 | $185,000 | -23.2% | 45,141 | 0.0% | 0.00% | -100.0% |
| Q4 2013 | $241,000 | +6.2% | 45,141 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $227,000 | +12.9% | 45,141 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $201,000 | – | 45,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 17,902,338 | $135,342,000 | 5.88% |
| TIGER MANAGEMENT L.L.C. | 1,288,454 | $9,741,000 | 1.91% |
| Phocas Financial Corp. | 1,047,181 | $7,917,000 | 0.69% |
| TUDOR INVESTMENT CORP ET AL | 2,370,503 | $17,921,000 | 0.62% |
| EAM Investors, LLC | 553,309 | $4,183,000 | 0.58% |
| Baker Brothers Advisors | 4,449,797 | $33,640,000 | 0.34% |
| TFS CAPITAL LLC | 463,740 | $3,506,000 | 0.33% |
| FEDERATED HERMES, INC. | 13,508,290 | $102,123,000 | 0.32% |
| Rotella Capital Management, Inc. | 36,473 | $276,000 | 0.24% |
| OXFORD ASSET MANAGEMENT LLP | 1,103,848 | $8,351,000 | 0.18% |